Skip to contentB
Biofrontera Inc.
B
BFRIBiofrontera Inc. Q1 2026 · 10-Q
Revenue$10.08M$10.08M+17.4% vs Q1 2025 Net Income-$4.75M-$4.75MN/M vs Q1 2025 EPS Diluted-$0.41-$0.41N/M vs Q1 2025 Operating Income-$4,320,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
Free Cash Flowderived-$75,000N/M Margins · derivedOperating margin-42.8%+10.1 pt vs Q1 2025
Net margin-47.1%+1.8 pt vs Q1 2025
ended Mar 31, 2026 · filed May 14, 2026 · 44 d after period end